Analytic Investors’s Albany Molecular Research Inc AMRI Stock Holding History

Analytic Investors’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-101,670	Closed	-$1.66M	–	642
2014 Q4	$1.66M	Sell	101,670 -2,686	-3%	-$49.3K	0.02%	277
2014 Q3	$2.3M	Buy	+104,356	New	+$2.14M	0.03%	245
2014 Q2	–	Sell	-103,083	Closed	-$1.92M	–	639
2014 Q1	$1.92M	Sell	103,083 -81,038	-44%	-$1.12M	0.03%	286
2013 Q4	$1.86M	Buy	184,121 +90,960	+98%	+$1.1M	0.03%	254
2013 Q3	$1.2M	Buy	+93,161	New	+$1.15M	0.02%	285

Other funds holding AMRI

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Analytic Investors's AMRI Position: Q1 2015 in Review

Analytic Investors sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 101,670 shares — an estimated $1.66M sold.

Analytic Investors first reported a position in AMRI in Q3 2013 and held it in 5 quarters. The position peaked at $2.3M in Q3 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

Analytic Investors reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
Analytic Investors sold 101,670 Albany Molecular Research Inc shares in Q1 2015, an estimated $1.66M.
Analytic Investors first reported a position in Albany Molecular Research Inc in Q3 2013 and held it in 5 quarters.
Analytic Investors's Albany Molecular Research Inc position peaked at $2.3M in Q3 2014.
131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on Analytic Investors's 13F filing for Q1 2015, filed 21 May 2015.